Semi-quantitative detection of inflammatory biomarkers using a laser-patterned multiplexed lateral flow device
Copyright © 2021 Elsevier B.V. All rights reserved..
Inflammatory markers including C-reactive protein (CRP) and procalcitonin (PCT) have been shown to be useful biomarkers to improve triage speed and prevent the inappropriate use of antibiotics for infections such as pneumonia. Here, we present a novel and exciting solution to guide the administration of antibiotic treatment via rapid, semi-quantitative and multiplexed detection of CRP and PCT using an advanced lateral flow device (LFD) designed to have multiple parallel flow-paths, produced via the precise laser-based partitioning of the single flow-path of a standard LFD. Each flow-path within this multiplexed LFD has a unique detection capability which permits tailored detection of CRP within a predefined cut-off range (20 μg/mL - 100 μg/mL) and PCT above a pre-defined threshold (0.5 ng/mL). We demonstrate the use of this LFD in the successful detection of CRP and PCT semi-quantitatively within spiked human serum samples. This multiplexed near-patient assay has potential for development into a rapid triage and treatment of patients with suspected pneumonia.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:237 |
---|---|
Enthalten in: |
Talanta - 237(2022) vom: 15. Jan., Seite 122944 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Iles, Alice H [VerfasserIn] |
---|
Links: |
---|
Themen: |
9007-41-4 |
---|
Anmerkungen: |
Date Completed 08.11.2021 Date Revised 08.11.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.talanta.2021.122944 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM332747662 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM332747662 | ||
003 | DE-627 | ||
005 | 20231225220219.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.talanta.2021.122944 |2 doi | |
028 | 5 | 2 | |a pubmed24n1109.xml |
035 | |a (DE-627)NLM332747662 | ||
035 | |a (NLM)34736671 | ||
035 | |a (PII)S0039-9140(21)00866-3 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Iles, Alice H |e verfasserin |4 aut | |
245 | 1 | 0 | |a Semi-quantitative detection of inflammatory biomarkers using a laser-patterned multiplexed lateral flow device |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 08.11.2021 | ||
500 | |a Date Revised 08.11.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2021 Elsevier B.V. All rights reserved. | ||
520 | |a Inflammatory markers including C-reactive protein (CRP) and procalcitonin (PCT) have been shown to be useful biomarkers to improve triage speed and prevent the inappropriate use of antibiotics for infections such as pneumonia. Here, we present a novel and exciting solution to guide the administration of antibiotic treatment via rapid, semi-quantitative and multiplexed detection of CRP and PCT using an advanced lateral flow device (LFD) designed to have multiple parallel flow-paths, produced via the precise laser-based partitioning of the single flow-path of a standard LFD. Each flow-path within this multiplexed LFD has a unique detection capability which permits tailored detection of CRP within a predefined cut-off range (20 μg/mL - 100 μg/mL) and PCT above a pre-defined threshold (0.5 ng/mL). We demonstrate the use of this LFD in the successful detection of CRP and PCT semi-quantitatively within spiked human serum samples. This multiplexed near-patient assay has potential for development into a rapid triage and treatment of patients with suspected pneumonia | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a C-reactive protein | |
650 | 4 | |a Lateral-flow device | |
650 | 4 | |a Multiplexed | |
650 | 4 | |a Point-of-care | |
650 | 4 | |a Procalcitonin | |
650 | 4 | |a Semi-quantitative | |
650 | 7 | |a Biomarkers |2 NLM | |
650 | 7 | |a Procalcitonin |2 NLM | |
650 | 7 | |a C-Reactive Protein |2 NLM | |
650 | 7 | |a 9007-41-4 |2 NLM | |
700 | 1 | |a He, Peijun J W |e verfasserin |4 aut | |
700 | 1 | |a Katis, Ioannis N |e verfasserin |4 aut | |
700 | 1 | |a Galanis, Panagiotis P |e verfasserin |4 aut | |
700 | 1 | |a John, Anto J U K |e verfasserin |4 aut | |
700 | 1 | |a Elkington, Paul |e verfasserin |4 aut | |
700 | 1 | |a Eason, Robert W |e verfasserin |4 aut | |
700 | 1 | |a Sones, Collin L |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Talanta |d 1966 |g 237(2022) vom: 15. Jan., Seite 122944 |w (DE-627)NLM114409137 |x 1873-3573 |7 nnns |
773 | 1 | 8 | |g volume:237 |g year:2022 |g day:15 |g month:01 |g pages:122944 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.talanta.2021.122944 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 237 |j 2022 |b 15 |c 01 |h 122944 |